Shi Yan-Jie, Li Xiao-Ting, Zhang Xiao-Yan, Liu Yu-Liang, Tang Lei, Sun Ying-Shi
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Oncotarget. 2017 Aug 24;8(41):71095-71104. doi: 10.18632/oncotarget.20533. eCollection 2017 Sep 19.
The retrospective study investigated accuracy of quantitative evaluation of T1-weighted imaging (T1WI) with and without fat suppression (FS), chemical-shift, diffusion-weighted imaging (DWI) and enhanced imaging at 3.0 T MRI for distinguishing spinal hemangiomas from metastases. 27 patients with 33 spinal hemangiomas (15 atypical hemangiomas) and 26 patients with 71 metastases were recruited. T1WI, FS T1WI, in- and out-phase, DWI and enhanced T1WI were acquired. Signal intensities (SIs) of lesions were obtained. Signal intensity ratios (SIRs) and enhancement ratios of lesions in enhanced imaging were assessed. Ratio of SI loss of hemangiomas or atypical hemangiomas between T1WI and FS T1WI was higher than those of metastases (p < 0.001). The accuracies of ratio of SI loss between T1WI and FS T1WI for differentiating hemangiomas and atypical hemangiomas from metastases were 96.15% and 91.86%. Ratio of SI loss between in- and out- phase could differentiate hemangiomas and atypical hemangiomas from metastases with accuracies of 74.04% and 84.88%. Cutoff values for hemangiomas in SIRs of ≤ 1.52 (early phase) and ≤ 1.38 (middle phase) yielded accuracies of 92.31% and 82.69%. Enhancement ratios of atypical hemangiomas in middle and delayed phases were higher than that of metastases. Accuracies of apparent diffusion coefficient for differentiating hemangiomas and atypical hemangiomas from metastases were 70.19% and 89.53%. T1WI with and without fat suppression could distinguish spinal hemangiomas from metastases. Quantitative assessment of chemical-shift, DWI and enhanced imaging were helpful to identification of spinal hemangiomas and metastases.
这项回顾性研究调查了3.0 T磁共振成像(MRI)下,有脂肪抑制(FS)和无脂肪抑制的T1加权成像(T1WI)、化学位移成像、扩散加权成像(DWI)以及增强成像在区分脊柱血管瘤和转移瘤方面的定量评估准确性。招募了27例患有33个脊柱血管瘤(15个不典型血管瘤)的患者以及26例患有71个转移瘤的患者。采集了T1WI、FS T1WI、同相位和反相位成像、DWI以及增强T1WI图像。获取病变的信号强度(SI)。评估增强成像中病变的信号强度比(SIR)和增强率。T1WI和FS T1WI之间血管瘤或不典型血管瘤的SI降低率高于转移瘤(p < 0.001)。T1WI和FS T1WI之间的SI降低率在区分血管瘤和不典型血管瘤与转移瘤方面的准确率分别为96.15%和91.86%。同相位和反相位之间的SI降低率在区分血管瘤和不典型血管瘤与转移瘤方面的准确率分别为74.04%和84.88%。SIRs中血管瘤的截断值≤1.52(早期)和≤1.38(中期)时,准确率分别为92.31%和82.69%。不典型血管瘤在中期和延迟期的增强率高于转移瘤。表观扩散系数在区分血管瘤和不典型血管瘤与转移瘤方面的准确率分别为70.19%和89.53%。有脂肪抑制和无脂肪抑制的T1WI能够区分脊柱血管瘤和转移瘤。化学位移成像、DWI和增强成像的定量评估有助于脊柱血管瘤和转移瘤的鉴别。